,outcome,arm 1,arm 2
0,intervention,topotecan group,paclitaxel
0,"median survival, 4 years","20.5 % censored, 63.0 weeks ( range < 1 to 238.4+ weeks","12.3 % censored, 53.0 weeks ( range < 1 to 226.3+ weeks"
